We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+11.75%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$65.7B
AUM Growth
+$6.62B
(+11%)
Cap. Flow
+$648M
Cap. Flow
% of AUM
0.99%
Top 10 Holdings %
Top 10 Hldgs %
27.2%
Holding
2,939
New
828
Increased
695
Reduced
744
Closed
553
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$412M |
| 2 |
Goldman Sachs
GS
|
+$374M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$347M |
| 4 |
Procter & Gamble
PG
|
+$320M |
| 5 |
Coca-Cola
KO
|
+$294M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$400M |
| 2 |
Constellation Brands
STZ
|
+$345M |
| 3 |
Meta Platforms (Facebook)
META
|
+$286M |
| 4 |
Kenvue
KVUE
|
+$277M |
| 5 |
AbbVie
ABBV
|
+$258M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.4% |
| 2 | Healthcare | 13.22% |
| 3 | Consumer Discretionary | 12.71% |
| 4 | Financials | 7.66% |
| 5 | Communication Services | 7.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
T. Rowe Price Blue Chip Growth ETF
TCHP
$2.07B
| $898K | ﹤0.01% |
25,438
+11,968
| +89% | +$400K |
|
1677
Cibus
CBUS
$148M
| $894K | ﹤0.01% |
+39,807
| New | +$732K |
|
|
SBDS
1678
DELISTED
Solo Brands Inc
SBDS
| $892K | ﹤0.01% |
+10,275
| New | +$1.18M |
|
1679
Energizer
ENR
$1.5B
| $887K | ﹤0.01% |
30,143
-162,756
| -84% | -$4.92M |
|
1680
Sturm, Ruger & Co
RGR
$611M
| $886K | ﹤0.01% |
19,194
+8,097
| +73% | +$358K |
|
1681
Pitney Bowes
PBI
$2.41B
| $879K | ﹤0.01% |
+202,924
| New | +$837K |
|
|
MCAAW
1682
CALL
DELISTED
Mountain & Co. I Acquisition Corp. Warrant
MCAAW
| $873K | ﹤0.01% |
75,614
| – | – |
|
1683
Scholastic
SCHL
$766M
| $872K | ﹤0.01% |
23,122
-71,030
| -75% | -$2.72M |
|
1684
Anika Therapeutics
ANIK
$202M
| $871K | ﹤0.01% |
34,292
+13,720
| +67% | +$332K |
|
|
ATSG
1685
DELISTED
Air Transport Services Group
ATSG
| $870K | ﹤0.01% |
63,223
-221,964
| -78% | -$3.2M |
|
1686
Tango Therapeutics
TNGX
$4.34B
| $868K | ﹤0.01% |
+109,269
| New | +$1.17M |
|
1687
Erie Indemnity
ERIE
$12.7B
| $863K | ﹤0.01% |
+2,148
| New | +$790K |
|
|
QDROW
1688
CALL
DELISTED
Quadro Acquisition One Corp. Warrant
QDROW
| $857K | ﹤0.01% |
77,580
-270,754
| -78% | -$12.4K |
|
1689
New Fortress Energy
NFE
$94.3M
| $857K | ﹤0.01% |
28,000
+6,406
| +30% | +$210K |
|
1690
Clearway Energy Class C
CWEN
$4.9B
| $856K | ﹤0.01% |
+37,144
| New | +$873K |
|
1691
Rhythm Pharmaceuticals
RYTM
$7.41B
| $856K | ﹤0.01% |
+19,750
| New | +$864K |
|
|
OBE
1692
Obsidian Energy
OBE
$628M
| $855K | ﹤0.01% |
104,051
+71,408
| +219% | +$500K |
|
1693
Manhattan Associates
MANH
$9.95B
| $854K | ﹤0.01% |
+3,414
| New | +$813K |
|
|
SYRS
1694
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $854K | ﹤0.01% |
159,584
+134,766
| +543% | +$932K |
|
|
LGVCW
1695
CALL
DELISTED
LAMF Global Ventures Corp. I Warrant
LGVCW
| $853K | ﹤0.01% |
105,181
| – | – |
|
1696
Verastem
VSTM
$547M
| $853K | ﹤0.01% |
+72,265
| New | +$835K |
|
1697
Lifecore Biomedical
LFCR
$165M
| $851K | ﹤0.01% |
160,233
+16,340
| +11% | +$117K |
|
1698
Marten Transport
MRTN
$1.25B
| $851K | ﹤0.01% |
+46,035
| New | +$885K |
|
1699
Sony
SONY
$133B
| $846K | ﹤0.01% |
+49,355
| New | +$907K |
|
1700
Mission Produce
AVO
$1.13B
| $845K | ﹤0.01% |
+71,189
| New | +$759K |
|
Similar funds
Marshall Wace's Q1 2024 Portfolio in Review
As of Q1 2024, Marshall Wace held 2,939 positions worth $65.7B, up 11% from $59B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Marshall Wace's Q1 2024 filing shows 828 new, 695 increased, 744 reduced and 553 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 900,000 shares worth $433M. The largest sale was Walmart Inc, an estimated $400M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Marshall Wace's largest Q1 2024 buy was Vanguard S&P 500 ETF: 900,000 shares worth $433M.
- Marshall Wace added most to Goldman Sachs in Q1 2024, an estimated $374M increase.
- Marshall Wace's biggest Q1 2024 reduction was Walmart Inc, cutting an estimated $400M.
- Marshall Wace fully exited Celsius Holdings in Q1 2024, selling an estimated $143M.
- Marshall Wace's ten largest holdings make up 27% of its $65.7B portfolio in Q1 2024.
- Marshall Wace opened 828 new positions and closed 553 in Q1 2024.
- Marshall Wace's portfolio value rose 11% quarter-over-quarter to $65.7B.
Based on Marshall Wace's 13F filing for Q1 2024, filed 15 May 2024.